Literature DB >> 11162777

Effect of cigarette smoke extract on neonatal porcine vascular smooth muscle cells.

N Ambalavanan1, W F Carlo, A Bulger, J Shi, J B Philips.   

Abstract

RATIONALE: Cigarette smoke exposure in the perinatal period increases the risk of various prenatal and postnatal complications, including sudden infant death syndrome (SIDS) and persistent pulmonary hypertension of the newborn (PPHN). We investigated the cellular effects of cigarette smoke extract (CSE) in the developing vasculature.
METHODS: Vascular smooth muscle cells (VSMC) were isolated from neonatal porcine carotid arteries, splenic arteries, and main and resistance pulmonary arteries. Effects of CSE on VSMC proliferation, viability, apoptosis, and media nitrates and nitrites were evaluated. The effects of known constituents of CSE (nicotine, benzopyrene, acrolein, acetaldehyde), aged CSE, CSE with added hemoglobin, devolatilized CSE, CSE with added dithiothreitol (DTT), and reduced glutathione (GSH) on cell proliferation and viability were assessed.
RESULTS: CSE caused a dose- and time-dependent decrease in neonatal VSMC numbers isolated from all four sites, mainly as a result of increased cell necrosis and not apoptosis. Nitrates and nitrites were below the threshold of detection. Nicotine and benzopyrene did not affect cell counts, while acrolein and acetaldehyde decreased cell counts in a dose-dependent manner. Addition of hemoglobin, devolatilization, and the addition of DTT or GSH slightly decreased CSE inhibition.
CONCLUSIONS: CSE causes necrosis of neonatal VSMC, and this toxicity is mediated mainly by volatile components such as acrolein and acetaldehyde, possibly in association with nitric oxide and carbon monoxide. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162777     DOI: 10.1006/taap.2000.9094

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Comparison of classical and non-classical cardiovascular risk factors influencing the patency of native arteriovenous fistulas after percutaneous transluminal angioplasty therapy among haemodialysis patients.

Authors:  Jiung-Hsiun Liu; Po-Wen Lin; Yao-Lung Liu; Hsin-Hung Lin; Chiu-Ching Huang
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

2.  Endogenous nitric oxide activation protects against cigarette smoking induced apoptosis in endothelial cells.

Authors:  Muthuswamy Raveendran; Jing Wang; Duraisamy Senthil; Jian Wang; Budi Utama; Ying Shen; Donald Dudley; Yun Zhang; Xing Li Wang
Journal:  FEBS Lett       Date:  2005-01-31       Impact factor: 4.124

3.  Involvement of TRPC1 and Cyclin D1 in Human Pulmonary Artery Smooth Muscle Cells Proliferation Induced by Cigarette Smoke Extract.

Authors:  Xun Wang; Wen Wang; Chan Liu; Xiao-Jun Wu
Journal:  Curr Med Sci       Date:  2021-01-11

4.  Cigarette smoke extract stimulates rat pulmonary artery smooth muscle cell proliferation via PKC-PDGFB signaling.

Authors:  Ai-ping Xing; Yong-cheng Du; Xiao-yun Hu; Jian-ying Xu; Huan-ping Zhang; Yi Li; Xin Nie
Journal:  J Biomed Biotechnol       Date:  2012-06-11

5.  Cigarette smoke extract promotes proliferation of airway smooth muscle cells through suppressing C/EBP-α expression.

Authors:  Pin Guan; Wentao Cai; Huapeng Yu; Zhiyong Wu; Wei Li; Jie Wu; Juan Chen; Guangqiu Feng
Journal:  Exp Ther Med       Date:  2017-02-15       Impact factor: 2.447

6.  Dual effects of cigarette smoke extract on proliferation of endothelial progenitor cells and the protective effect of 5-aza-2'-deoxycytidine on EPCs against the damage caused by CSE.

Authors:  Zhi-Hui He; Ping Chen; Yan Chen; Ying-Qun Zhu; Sheng-Dong He; Ji-Ru Ye; Da Liu; Yue Yang
Journal:  Biomed Res Int       Date:  2014-02-18       Impact factor: 3.411

Review 7.  The Role of Maternal Smoking in Sudden Fetal and Infant Death Pathogenesis.

Authors:  Nadja Bednarczuk; Anthony Milner; Anne Greenough
Journal:  Front Neurol       Date:  2020-10-23       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.